Champions Oncology Reports $15.2 Million Q1 Revenue

8 sourcesUpdated Sep 11, 2026

Champions Oncology reported first-quarter fiscal 2027 revenue of $15.2 million, up 8.8% year over year, while adjusted EBITDA increased to $671,000 from $59,000 and marked the company’s fifth consecutive quarter of positive adjusted EBITDA. Translational oncology services revenue reached $14.3 million, and the segment’s margin improved to 51% from 43% as in-house radiolabeling reduced costs and higher revenue created operating leverage. Data licensing revenue rose to $893,000, surpassing the total for all of fiscal 2026, as the company expanded its customer base and sought broader applications for its clinically annotated oncology data. Champions ended the quarter with about $4.4 million in cash and no debt, despite reporting a GAAP net loss of approximately $426,000. Separately, the company expanded its radiopharmaceutical development platform with in-house SPECT/CT imaging, enabling longitudinal tracking of drug uptake alongside biodistribution and therapeutic-response data in patient-derived tumor models.

Sponsored

In this story:

Sponsored

More on this story

Back to News

Finance

Frequency Electronics Posts Record Revenue, Backlog

Frequency Electronics reported a record for fiscal Q1 2027 with revenue of $23.5 million, up 70% year over year, and backlogged orders of $129 million while expanding margins to 45.8% gross and 22% operating; net income was about $4.2 million as the company reaffirms long-term targets of at least $150 million in annual revenue by 2029, supported by capacity expansion and strong space and defense demand. The firm remains debt-free with ample cash, and growth is driven by satellite, missile-defense, and secure communications programs with ongoing insider and institutional interest in the stock.

13 sources

Finance

Oil Tops $100 as Middle East Risks Grow

1

100%

Other

7

Total sources8

Last updatedSep 11, 2026

Does this breakdown look right?

Sponsored

How it spread

Broke ainvest.com · Sep 7, 7:14 PM ETRight +3d8 sources +3d on

Claim check

What each side asserts, disputes — or leaves out entirely.

Analyzing the coverage…

Where do you land?

Whose framing of this story rings truest to you?

Sponsored

Coverage

Sponsored

Comments

Ask Genius by OpenServe:

Free account · your comment posts right after signup

Sponsored

Global oil markets remain under pressure from Middle East disruptions, with Brent hovering around $100 as Hormuz and Saudi facility issues tighten supply, fueling inflation risks and prompting cautious policy stances. Analysts warn equities could correct as energy risks mount and think tanks highlight the volatile transition and potential macro-financial spillovers from producer fragility.

173 sources

Sponsored

Business

Copart Agrees to Acquire ACV for $1.9 Billion

Copart has agreed to acquire ACV Auctions for about $1.9 billion in cash at $10.50 per ACV share, a roughly 45% premium, with a back-end merger expected to close by year-end 2026 and funded from Copart’s cash on hand. The deal expands Copart’s platform into dealer-to-dealer wholesale and enhances its data and AI capabilities, though investors weigh potential integration risks and the impact on cash reserves, while analysts see potential earnings accretion in the long term.

12 sources